Detalhe da pesquisa
1.
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.
Br J Haematol
; 203(2): 264-281, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539479
2.
Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation.
Haematologica
; 108(8): 2080-2090, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794500
3.
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT.
Br J Haematol
; 184(5): 782-787, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30467839
4.
Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.
BMC Cancer
; 19(1): 287, 2019 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30925912
5.
A wild bootstrap approach for the Aalen-Johansen estimator.
Biometrics
; 74(3): 977-985, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451947
6.
Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 92(10): 997-1003, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28614903
7.
Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia.
Haematologica
; 101(7): 879-83, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27081178
8.
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
BMC Cancer
; 16: 282, 2016 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27098429
9.
Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency.
J Allergy Clin Immunol
; 135(4): 988-997.e6, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25595268
10.
Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Br J Haematol
; 171(2): 239-246, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26212516
11.
A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation.
Ann Hematol
; 93(2): 293-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23907410
12.
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial.
Lancet Haematol
; 11(3): e196-e205, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301670
13.
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 59(2): 217-223, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978322
14.
Conjunctival HLA-DR and CD8 expression detected by impression cytology in ocular graft versus host disease.
Mol Vis
; 19: 1492-501, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23878500
15.
Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation.
Ann Hematol
; 92(1): 111-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22968661
16.
An internal validation approach and quality control on hematopoietic chimerism testing after allogeneic hematopoietic cell transplantation.
Clin Chem Lab Med
; 51(2): 363-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23093278
17.
Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT.
Eur J Haematol
; 89(3): 214-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22702414
18.
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia.
Bone Marrow Transplant
; 57(2): 215-223, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750562
19.
Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.
Haematologica
; 96(9): 1344-50, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21659356
20.
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Lancet Haematol
; 7(1): e28-e39, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606445